-
Stem Cells and the Lawsuit That May Shape Our Medical Future – Courtesy (Forbes)
Regenerative Sciences, a medical company that pioneered a procedure to treat orthopedic injuries using patients’ own stem cells, is...
-
Supreme Court Calls For Some Deference In Claim Construction Standard Of Review – Courtesy (Pharma Patents)
POSTED BY COURTENAY C. BRINCKERHOFF ON 22 JANUARY 2015POSTED IN CLAIM CONSTRUCTION;SUPREME COURT DECISIONSOn January 20, 2015, the Supreme Court issued its...
-
Court Cites Objects Of Invention In Claim Construction – Courtesy (Pharma Patents)
POSTED BY COURTENAY C. BRINCKERHOFF ON 24 FEBRUARY 2015POSTED IN CLAIM CONSTRUCTION;FEDERAL CIRCUIT DECISIONSPacing Technologies, LLC v. Garmin International, Inc. is one of...
-
Suven Life Sciences gets patents for neurological drug
Suven Life Sciences gets patents for neurological drug
-
Erytech Strengthens Its Intellectual Property Position In The U.S. – Courtesy(Biospace)
ERYTECH (Paris:ERYP) (ADR:EYRYY), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications...
-
FDA Releases Draft Guidance on Biosimilars
POSTED BY COURTENAY C. BRINCKERHOFF ON 9 FEBRUARY 2012POSTED IN BIOSIMILARSOn February 9, 2012, the FDA issued long-awaited (draft) guidance documents on...
-
-
Federal Circuit Finds No Direct Infringement Of Akamai Patents – Courtesy (Pharma Patents)
POSTED BY COURTENAY C. BRINCKERHOFF ON 19 MAY 2015POSTED IN FEDERAL CIRCUIT DECISIONS;INFRINGEMENTThe Federal Circuit issued its remand decision in Akamai Technologies, Inc....
